Japan Hosts $980 Million in API-Related Pharma Projects

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking more than 40 capital-spending projects across Japan related to the development of active pharmaceutical ingredients (API), totaling more than US$970 million of investment value.

Projects include the expansion of ID Pharma Company Limited's plant for the production of highly potent APIs, including COVID-19 vaccine APIs and fill & finish projects. Construction began in the first quarter of 2023 and is expected to wrap up in 2024. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharma-Biotech Project Database can learn more from a detailed project report.

Subscribers can click here for a list of detailed projects reports, and can click here for a list of related plant profiles.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).